Palliative Care in Adolescents and Young Adults

  • Anna-Karenia AndersonEmail author


Despite cancer continuing to be the third leading [1] cause of death in adolescents and young adult (AYA); palliative care is often only been considered towards end of life [2]. The majority of AYAs with progressing or relapsing disease continue to die in hospital receiving cancer-directed therapies [3]. With access to more clinical trials and further lines of therapies, the AYA may live longer, burdened with increasingly complex symptoms, as a result of their cancer or its treatment. This, and the recent evidence [4] of early palliative care input having a life prolonging effect even in the face of less cancer-directed therapy and active intervention at end of life, supports its early introduction, from either diagnosis 57 or first relapse.


  1. 1.
    Eurostat,_by_age_group,_EU-28,_2011.png.Google Scholar
  2. 2.
    Keim-Malpass J, Erickson JM, Malpass HC. End-of-life care characteristics for young adults with cancer who die in the hospital. J Palliat Med. 2014;17(12):1359–64.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Cohen-Gogo S, Marioni G, Laurent S, Gaspar N, Semeraro M, Gabolde M, Dufour C, Valteau-Couanet D, Brugières L. End of life care in adolescents and young adults with cancer: experience of the adolescent unit of the Institut Gustave Roussy. Eur J Cancer. 2011;47(18):2735–41.CrossRefPubMedGoogle Scholar
  4. 4.
    Temel J, Greer J, Muzikansky A, Gallagher E, Admane S, Jackson V, Dahlin C, Blinderman C, Jacobsen J, Pril W, Billings J, Lynch T. Early palliative care for patients with metastatic no-small cell lung cancer. N Engl J Med. 2010;363:733–42.CrossRefPubMedGoogle Scholar
  5. 5.
    Jalmsell L, Lövgren M, Kreicbergs U, Henter JI, Frost BM. Children with cancer share their views: tell the truth but leave room for hope. Acta Paediatr. 2016;105(9):1094–9.CrossRefPubMedGoogle Scholar
  6. 6.
    George R, Hutton S. Palliative care in adolescents. Euro J Cancer. 2003;39(18):2662–8.CrossRefGoogle Scholar
  7. 7.
    Grinyer A, Barabarachild Z. Teenage and young adult palliative and end of life care service evaluation. London: Teenage Cancer Trust; 2011.Google Scholar
  8. 8.
    Valdez-Marinez E, Noyes J, Bedolla M. When to stop ? Decision-making when children’s cancer treatment is no longer curative : a mixed-method systematic review. BMC Ped. 2014;14:124.CrossRefGoogle Scholar
  9. 9.
    Masso M, Allingham SF, Banfield M, Johnson CE, Pidgeon T, Yates P, Eagar K. Palliative care phase: inter-rater reliability and acceptability in a national study. Palliat Med. 2014;29(1):22–30.CrossRefPubMedGoogle Scholar
  10. 10.
    Montel S, Laurence V, Copel L, Paquement H, Flahault C. Place of death in adolescents and young adults with cancer: first study in a French population. Palliative and supportive care. 2009;7:27–35.CrossRefPubMedGoogle Scholar
  11. 11.
    Jacobs S, Perez J, Cheng YI, Sill A, Wang J, Lyon ME. Adolescent end of life preferences and congruence with their parents’ preferences: results of a survey of adolescents with cancer. Pediatr Blood Cancer. 2015;62(4):710.CrossRefPubMedGoogle Scholar
  12. 12.
    Bluebond-Langnar M, Belasco J, Goldman A, Belasco C. Understanding parents’ approaches to care and treatment of children with cancer when standard therapy has failed. J Clin Onco. 2007;25(17):2414–9.CrossRefGoogle Scholar
  13. 13.
    Hammes BJ, Klevan J, Kempf M, Williams MS. Pediatric advance care planning. J Palliat Med. 2005;8:766–73.CrossRefPubMedGoogle Scholar
  14. 14.
  15. 15.
    Lyon ME, Jacobs S, Briggs L, Cheng YI, Wang J. Family-centered advance care planning for teens with cancer. JAMA Pediatr. 2013;167(5):460–7.CrossRefPubMedGoogle Scholar
  16. 16.
    Lyon ME, Jacobs S, Briggs L, Cheng YI, Wang J. A longitudinal, randomised, controlled trial of advance planning for teens with cancer: anxiety, depression, quality of life, advance directive, spiruality. J Adolesc Health. 2014;54(6):710–7.CrossRefPubMedGoogle Scholar
  17. 17.
    Zadeh S, Pao M, Weiner L. Opening end of life discussion: how to introduce voicing my CHOiCES, an advance care planning guide of adolescents and young adults. 2014 1478. ACP for AYA. Pediatr Blood Cancer. 2013;60(5):715–8.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
  19. 19.
    Weaver MS, Heinze KE, Bell CJ, Wiener L, Garee AM, Kelly KP, Casey RL, Watson A. Hinds PS; establishing psychosocial palliative care standards for children and adolescents with cancer and their families: an integrative review. Palliat Med. 2016;30(3):212–23.CrossRefPubMedGoogle Scholar
  20. 20.
    Bates AT, Kearney JA. Understanding death with limited experience in life: dying children’s and adolescents’ understanding of their own terminal illness and death. Curr Opin Support Palliat Care. 2015;9(1):40–5.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Harding R, Simms V, Calanzani N, Higginson IJ, Hall S, Gysels M, Meñaca A, Bausewein C, Deliens L, Ferreira P, Toscani F, Daveson BA, Ceulemans L, Gomes B. If you had less than a year to live, would you want to know? A seven-country European population survey of public preferences for disclosure of poor prognosis. Psychooncology. 2013 Oct;22(10):2298–305.PubMedGoogle Scholar
  22. 22.
    Wiener L, Zadeh S, Battles H, Baird K, Ballard E, Osherow J, Pao M. Allowing adolescents and young adults to plan their end of life care. Ped. 2012;130(5):897–905.CrossRefGoogle Scholar
  23. 23.
    Fraser J, Harris N, Berringer AJ, Prescott H, Finlay F. Advanced care planning in children with life-limiting conditions—the wishes document. Arch Dis Child. 2010;95(2):7982.CrossRefGoogle Scholar
  24. 24.
    Warnick AL. Supporting youth grieving the dying or death of a sibling or parent: considerations for parents, professionals, and communities. Curr Opin Support Palliat Care. 2015;9(1):58–63.CrossRefPubMedGoogle Scholar
  25. 25.
    Wolff A, Browne J, Whitehouse W. Personal resuscitation plans and end of life planning for children with diasability and life-limiting/life threatening conditions. Arch Dis Child Educ Prac Ed. 2011;96:42–8.CrossRefGoogle Scholar
  26. 26.
    Breault J. DNR, DNAR or AND? Is language important? Ochsner J. 2011;Winter 11(4):302–6.PubMedGoogle Scholar
  27. 27.
    Sokol D. The death of DNR. BMJ. 2009;338:b1723.CrossRefPubMedGoogle Scholar
  28. 28.
    Wiener L, Zadeh S, Wexler LH, Pao M. When silence is not golden: engaging adolescents and young adults in discussions around end-of-life care choices. Pediatr Blood Cancer. care. 2013;60(5):715–8.CrossRefGoogle Scholar
  29. 29.
    Kondryn H, Edmondson C, Hill J, Eden T. Treatment non-adherence to teenage and young patients with cancer. Lancet Oncol. 2011;12(1):100–8.CrossRefPubMedGoogle Scholar
  30. 30.
    Kamperidis N, Goodhand J, Chowdhury F, Koodun Y, Direzke N, Naik S, Sanderson I, Croft N, Langmead F, Irving P, Rampton D, Lindsay J. Factors associated with nonadherence to Thiopurines in adolescents and adult patients with inflammatory bowel disease. J Ped Gastro Nutrition. 2012;54(5):685–9.CrossRefGoogle Scholar
  31. 31.
    Landier W. Adherence to oral chemotherapy in childhood acute lymphoblastic leukaemia : an evolutionary concept analysis. Onco Nursing Forum. 2011;38(3):343–52.CrossRefGoogle Scholar
  32. 32.
    Anghelescu DL, Zhang K, Faughnan LG, Pei D. The safety and effectiveness of patient-controlled analgesia in outpatient children and young adults with cancer: a retrospective study. J Pediatr Hematol Oncol. 2015 Jul;37(5):378–82.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Othman A, Mohamad M, Sayed H. Transdermal fentanyl for cancer pain management in opioid-naïve pediatric cancer patients. Pain Med. 2016;17(7):1329–36.CrossRefGoogle Scholar
  34. 34.
    Likar R. Transdermal buprenorphine in the management of persisting pain-safety aspects. Ther Clin Risk Manage. 2006;2(1):115–25.Google Scholar
  35. 35.
    Seyfried O, Hester J. Opioids and endocrine dysfunction. Br J Pain. 2012;6(1):17–24.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Anghlescu D, Patel R, Mahoney D, Trujillo L, Faughnan L, Steen B, Baker J, Pei D. Methadone prolongs cardiac conduction in young patients with cancer-realted pain. J Opioid Manag. 2016;12(2):131–8.CrossRefGoogle Scholar
  37. 37.
    Rasmussen V, Lundberg V. Extreme doses of intravenous methadone for severe pain in two children with cancer. Pediatr Blood Cancer. 2015;62:1087–90.CrossRefPubMedGoogle Scholar
  38. 38.
    Bredlau A, McDermott M, Adams H, Dworkin R, Venuto C, Fisher S, Dolan J, Korones D. Oral ketamine for children with chronic pain: a pilot phase 1 study. J Pediatr. 2013;163(1):194–2000.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Bredlau A, Thakur R, Korones D, Dworkin R. Ketamine for pain in adults and children with cancer: a systematic review and synthesis of the literature. Pain Med. 2013;14(10):1505–17.CrossRefPubMedGoogle Scholar
  40. 40.
    WHO Guidelines on the pharmacological treatment of persisting pain in children with medical illness 2012.Google Scholar
  41. 41.
    Paulsen Ø, Aass N, Kaasa S, Dale O. Do corticosteroids provide analgesic effects in cancer patients? A systematic literature review. J Pain Symptom Manag. 2013 Jul;46(1):96–105.CrossRefGoogle Scholar
  42. 42.
    Butkovic D, Tljan S, Mihovilovic-Novak B. Experience with gabapentin for neuropathic pain in adolescents: report of five cases. Paediatr Anaesth. 2006;16(3):325–9.CrossRefPubMedGoogle Scholar
  43. 43.
    Vondracek P, Oslejskova H, Kepak T, Mazanek P, Sterba J, Rysava M, Gal P. Efficayc of pregablin in neuropathic pain in paediatric oncological patients. Eur J Paediatr Neurol. 2009;13(4):332–6.CrossRefPubMedGoogle Scholar
  44. 44.
    Nayak S, Cunliffe M. Lidocaine 5% patch for localized chronic neuropathic pain in adolescents: report of five cases. Paediatr Anaesth. 2008;18(6):554–8.CrossRefPubMedGoogle Scholar
  45. 45.
    Valrie C, Bromberg M, Palermo T, Schanberg L. A systematic review of sleep in pediatric pain populations. J Dev Behav Pediatr. 2013 Feb;34(2):120–8.CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Walter L, Nixon G, Davey M, Downie P, Horne R. Sleep and fatigue in pediatric oncology : a review of the literature. Sleep Med Rev. 2015;24:71–81.CrossRefPubMedGoogle Scholar
  47. 47.
    Yennurajalingam S, Bruera E. Role of corticosteroids for fatigue in advanced incurable cancer: is it a ‘wonder drug’ or ‘deal with the devil’. Curr Opin Support Palliat Care. 2014;8(4):346–51.CrossRefPubMedGoogle Scholar
  48. 48.
    Miller S, McNutt L, McCann MA, McCorry N. Anorexia in palliative medicine: a systematic review. J Palliat Med. 2014;17(4):482–5.CrossRefPubMedGoogle Scholar
  49. 49.
    Sizoo EM, Grisold W, Taphoorn MJ. Neurologic aspects of palliative care: the end of life setting. Handb Clin Neurol. 2014;121:1219–25.CrossRefPubMedGoogle Scholar
  50. 50.
    Berger J, Lester P, Rodrigues L. Medical therapy of malignant bowel obstruction with Octreotide, dexamethasone, and metoclopramide. Am J Hosp Palliat Care. 2016;33(4):407–10.CrossRefPubMedGoogle Scholar
  51. 51.
    Levine DR, Johnson LM, Mandrell BN, Yang J, West NK, Hinds PS, Baker JN. Does phase 1 trial enrollment preclude quality end-of-life care? Phase 1 trial enrollment and end-of-life care characteristics in children with cancer. Cancer. 2015;121(9):1508–12.CrossRefPubMedGoogle Scholar
  52. 52.
    Keim-Malpass J, Stegenga K, Loudin B, Kennedy C, Kools S. “It's back! My remission is over”: online communication of disease progression among adolescents with cancer. J Pediatr Oncol Nurs. 2016;33(3):209–17.CrossRefPubMedGoogle Scholar
  53. 53.
    Mack JW, Chen LH, Cannavale K, Sattayapiwat O, Cooper RM, Chao CR. End-of-life care intensity among adolescent and young adult patients with cancer in Kaiser Permanente Southern California. JAMA Oncol. 2015;1(5):592–600.CrossRefPubMedPubMedCentralGoogle Scholar
  54. 54.
    White R, Bradnam V. Handbook of drug administration via enteral feeding tubes. 3rd ed; 2015.Google Scholar
  55. 55.
    Dickman A, Schneider J, Varga J. The syringe driver: continuous subcutaneous infusions in a palliative care. 2005.Google Scholar
  56. 56.
    Rosenberg AR, Postier A, Osenga K, Kreicbergs U, Neville B, Dussel V, Wolfe J. Long-term psychosocial outcomes among bereaved siblings of children with cancer. J pain symptom manage. 2015;49(1):55–65.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  1. 1.Royal Marsden HospitalSuttonUK

Personalised recommendations